Hyperfractionated-accelerated or conventionally fractionated radiotherapy for early glottic cancer

International Journal of Radiation Oncology Biology Physics

Volumn 52, Issue 1, 2002, Pages 109-119

  Haugen, Hedda ^a   Johansson, Karl Axel ^a   Mercke, Claes ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Glottic carcinoma; Hyperfractionated accelerated radiotherapy; Treatment time

Indexed keywords

BIOMEDICAL ENGINEERING; DISEASE CONTROL; ONCOLOGY; PATIENT TREATMENT; TUMORS;

TREATMENT TIME;

RADIOTHERAPY;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER STAGING; CONTROLLED STUDY; FEMALE; GLOTTIS; HUMAN; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DOSE; RADIOTHERAPY; SURVIVAL; TECHNIQUE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; GLOTTIS; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; SURVIVAL ANALYSIS; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0036140326     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)01812-0     Document Type: Article

References (39)

1. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiation therapy; Relationship of dose-fractionation factors to local control and complications
2. The effect of treatment time and interruption on tumor control following radical radiotherapy of laryngeal cancer
3. Do overall treatment time, field size, and treatment energy influence local control of T1-T2 squamous cell carcinoma of the glottic larynx?
4. The effect of overall treatment time of radiation therapy on local control of T1-stage squamous cell carcinoma of the glottis
5. Influence of fractionation size, total dose, and overall treatment time on local control of T1-T2 glottic carcinoma
6. Larynx
7. Definitive radiotherapy for early glottic carcinoma; Prognostic factors and implications for treatment
8. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiotherapy; A multivariate analysis of variables potentially influencing local control
9. Radiation therapy for T1,2 glottic carcinoma; Impact of overall treatment time on local control
10. Loss of local control with prolongation in radiotherapy
11. Randomized clinical trial on 7-day continuous accelerated irradiation (CAIR) of head and neck cancer-report on 3-year tumor control and normal tissue toxicity
12. Does tumor control decrease by prolonging treatment time or interrupting treatment in laryngeal cancer?
13. Does prolonged treatment course adversely effect local control of carcinoma of the larynx?
14. Repopulation during radical radiotherapy for T1 glottic cancer
15. Overview of late effects normal tissues (LENT) scoring system
16. Late effects toxicity scoring; the SOMA scale
17. Prognostic factors of local control after radiotherapy in T1 glottic and supraglottic carcinoma of the larynx
18. Radiation treatment of glottic squamous cell carcinoma, stage 1 and 2; Analysis of factors affecting prognosis
19. Early-stage glottic cancer; Importance of dose fractionation in radiation therapy
20. Prognostic factors for local control of early glottic cancer; The Rabin Medical Center retrospective study on 207 patients
21. 1 squamous cell carcinoma of the glottis
22. T1/T2 glottic cancer managed by external beam radiotherapy; The influence of pretreatment hemoglobin on local control
23. Accelerated radiotherapy for T1,2 glottic carcinoma; Analysis of results with Ki-67 index
24. Primary radiotherapy for glottic laryngeal carcinoma stage 1 and 2. A retrospective study with special regard to failure patterns
25. Twice-a-day radiotherapy for squamous cell carcinoma of the head and neck; The University of Florida experience
26. Twice a day versus once a day radiation therapy in head and neck cancer
27. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma; Final analysis of a randomized trial of the EORTC cooperative group of radiotherapy
28. Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancer
29. Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinoma
30. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation
31. Importance of overall time factor in postoperative radiotherapy
32. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves locoregional control in the radiotherapy of advanced head and neck cancers. Results of the EORTC 22851 randomized trial
33. Conventional radiotherapy as primary treatment of squamous cell carcinoma of the head and neck; A randomized multicenter study of 5 versus 6 fractions per week-report from the DAHANCA 7 trial
34. A randomized multicenter trial of CHART versus conventional radiotherapy in head and neck cancer
35. Does the interval between fractions matter in the range of 4-8 h in radiotherapy? A study of acute and late human skin reactions
36. A prospective quality of life study of patients with laryngeal carcinoma by tumor stage and different radiation therapy schedules